CONRAY 43 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Conray 43, and when can generic versions of Conray 43 launch?
Conray 43 is a drug marketed by Liebel-flarsheim and is included in one NDA.
The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CONRAY 43?
- What are the global sales for CONRAY 43?
- What is Average Wholesale Price for CONRAY 43?
Summary for CONRAY 43
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 440 |
| DailyMed Link: | CONRAY 43 at DailyMed |
Pharmacology for CONRAY 43
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for CONRAY 43
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liebel-flarsheim | CONRAY 43 | iothalamate meglumine | INJECTABLE;INJECTION | 013295-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
